Ramkumar Mandalam
Direttore/Membro del Consiglio presso CRYOPORT, INC.
Patrimonio netto: 387 181 $ in data 30/06/2024
Profilo
Ramkumar Mandalam is the founder of Citra Bioconsulting, Inc. (founded in 2021) and currently holds the position of Chief Executive Officer.
He is also currently working as the President, Chief Executive Officer & Director at Cellerant Therapeutics, Inc. since 2005.
Additionally, he serves as an Independent Director at CryoPort, Inc. since 2014 and as a Director at Stempeutics Research Pvt.
Ltd.
Dr. Mandalam previously worked as the Executive Director-Product Development at Geron Corp.
and as the Director-Developmental Research at Vericel Corp.
from 1994 to 2000.
He obtained a doctorate degree from the University of Michigan.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CRYOPORT, INC.
0.11% | 17/05/2024 | 56 032 ( 0.11% ) | 387 181 $ | 30/06/2024 |
Posizioni attive di Ramkumar Mandalam
| Società | Posizione | Inizio |
|---|---|---|
| CRYOPORT, INC. | Direttore/Membro del Consiglio | 16/06/2014 |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Amministratore Delegato | 01/01/2005 |
Stempeutics Research Pvt. Ltd.
 Stempeutics Research Pvt. Ltd. Pharmaceuticals: MajorHealth Technology Stempeutics Research Pvt. Ltd. is a clinical-stage biotech company based in Bangalore, India. The private company was founded in 2006 by Manipal Education and Medical Group (MEMG) and has since formed strategic alliances with Cipla in 2009 and with Kemwell in 2019. Stempeutics specializes in developing innovative stem cell products through cutting-edge research and clinical applications. Its highly qualified team is dedicated to developing novel cell therapy drugs to address major unmet medical needs with a first-next approach. | Direttore/Membro del Consiglio | - |
| Citra Bioconsulting, Inc. | Amministratore Delegato | 01/01/2021 |
Precedenti posizioni note di Ramkumar Mandalam
| Società | Posizione | Fine |
|---|---|---|
| VERICEL CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/01/2000 |
| GERON CORPORATION | Corporate Officer/Principal | - |
Formazione di Ramkumar Mandalam
| University of Michigan | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GERON CORPORATION | Health Technology |
| VERICEL CORPORATION | Health Technology |
| CRYOPORT, INC. | Transportation |
| Aziende private | 3 |
|---|---|
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Health Technology |
Stempeutics Research Pvt. Ltd.
Stempeutics Research Pvt. Ltd. Pharmaceuticals: MajorHealth Technology Stempeutics Research Pvt. Ltd. is a clinical-stage biotech company based in Bangalore, India. The private company was founded in 2006 by Manipal Education and Medical Group (MEMG) and has since formed strategic alliances with Cipla in 2009 and with Kemwell in 2019. Stempeutics specializes in developing innovative stem cell products through cutting-edge research and clinical applications. Its highly qualified team is dedicated to developing novel cell therapy drugs to address major unmet medical needs with a first-next approach. | Health Technology |
| Citra Bioconsulting, Inc. |
- Borsa valori
- Insiders
- Ramkumar Mandalam
